MEDICINOVA, INC. Current Income Tax Expense (Benefit)
MEDICINOVA, INC. (MNOV) reported Current Income Tax Expense (Benefit) of $5.99 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-10
- MEDICINOVA, INC. current income tax expense (benefit) for fiscal 2025 was $5.99K, a 8.25% increase from fiscal 2024.
- MEDICINOVA, INC. current income tax expense (benefit) for fiscal 2024 was $5.54K, a 81.72% increase from fiscal 2023.
- MEDICINOVA, INC. current income tax expense (benefit) for fiscal 2023 was $3.05K, a 7.97% increase from fiscal 2022.
- MEDICINOVA, INC. current income tax expense (benefit) for fiscal 2022 was $2.82K, a 9.89% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $5.99K 10-K · filed 2026-03-10 |
| 2024-12-31 | $5.54K 10-K · filed 2026-03-10 |
| 2023-12-31 | $3.05K 10-K · filed 2025-02-19 |
| 2022-12-31 | $2.82K 10-K · filed 2024-02-15 |
| 2021-12-31 | $2.57K 10-K/A · filed 2023-03-28 |
| 2020-12-31 | -$1.65K 10-K · filed 2022-02-16 |
| 2019-12-31 | $12.66K 10-K · filed 2021-02-19 |
| 2018-12-31 | $5.28K 10-K · filed 2020-02-13 |
| 2017-12-31 | $10.16K 10-K · filed 2019-02-13 |
| 2016-12-31 | $3.75K 10-K · filed 2019-02-13 |
| 2015-12-31 | $7.36K 10-K · filed 2018-02-13 |
| 2014-12-31 | -$3.97K 10-K · filed 2017-02-14 |
| 2013-12-31 | $4.04K 10-K · filed 2015-03-12 |
| 2012-12-31 | $11.14K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |